NKTX
NkartaANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
NKTX vs peer average
79/100
NKTX vs. peer average (A vs. C)
Grade spread
A 3 · B 4 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
CABA is the first available peer comparator.
Loose monitoring comparator only. Cabaletta Bio is a clinical-stage autoimmune cell-therapy reference point with readout-driven volatility, but its autologous CAR-T approach differs from Nkarta's allogeneic CAR-NK platform, so it should not be used as direct operating validation.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NKTX
Nkarta
CABA
Cabaletta Bio
Grade
A
B
Momentum
88
89
Value
58
41
Sentiment
43
47
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs CABA
NKTX / CABA
Grade Position
Above peers
NKTX vs. peer average (A vs. C)
79/100
Momentum
88
CABAValue
58
NKTXSentiment
43
CABARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NKTX
CABA is the first peer returned for this comparison set.